Moderna and Merck & Co. have developed a cancer vaccine that cuts the risk of death or recurrence of most deadly skin cancer by 44 percent compared to Merck's Keytruda on its own, according to researchers.
Share:
More In Science
On A Positive Note: ‘Miracle Medical Gel’ Used To Save Pets’ Lives
A new gel that helps stop bleeding for both emergency care and surgical procedures in animal medicine is being sought for FDA approval for a human version.
US Pregnancy Deaths Dropped in 2022, After COVID Spike
In this photo provided by Henry Danner, Omari Maynard sits with his children, Khari, left, and, Anari, holding a photo of their late mother, Shamony Gibson, at home in the Brooklyn borough of New York on April 9, 2022. Gibson passed away in 2019, two weeks after giving birth to Khari due to a pulmonary embolism. “She wasn’t being heard at all,” said Maynard, an artist who now does speaking engagements as a maternal health advocate.
NASA James Webb Space Telescope Spots Star Nearing Supernova
NASA's James Webb Space Telescope has caught a rare glimpse of one of the most massive and brightest stars known nearing supernova.
Mortality Rates For Children & Teens Surged In 2020, 2021
A study showed that death rates for kids and teenagers surged in 2020 and 2021.
What Are Harmful 'Forever Chemicals' and How Can They Make You Sick
The Environmental Protection Agency has proposed a new plan to lower the cap on the amount of harmful "forever chemicals" allowed in drinking water across the country.
Google Unveils Health Updates at ‘The Check Up’ Health Event
Google Unveils Health Updates at ‘The Check Up’ Health Event
Nor’easter Hits the Northeast
Nor’easter Hits the Northeast
Neurologist Says Diet and Mental Exercise Can Help Prevent Alzheimer's
Dr. Joel Salinas, clinical assistant professor of neurology at NYU Langone Health and chief medical officer at Isaac Health, spoke with Cheddar News anchor Shannon LaNier about Alzheimer's disease and struggles to find an effective treatment.
Novo Nordisk Slashes Insulin Drug Prices By 75%
Novo Nordisk is lowering the list prices of its Insulin drug, following Eli Lilly's lead earlier this month.
